Analyzing bioimpedance in healthy newborns in China
Official title: Application of Bioimpedance Vector Analysis in Neonates
Run by Zhujiang Hospital · NCT06188377 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how body composition in healthy newborns in China is measured using a special tool to see if it differs from babies in other countries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 24 Hours |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Zhujiang Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06188377 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy term neonates of both sexes within 24 hours of birth.
✕Probably not a fit
Patients who may not benefit from this study include those with diseases or conditions affecting body composition, such as heart failure or congenital anomalies.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the distribution of bioimpedance vectors in healthy neonates within the first 24 hours of life in China. Using a NUTRILAB impedance analyzer, the study will collect demographic and health data from medical records and perform bioimpedance analysis on randomly selected newborns. Measurements will be taken under controlled conditions to ensure accuracy, and the results will be compared to similar data from other countries to assess any differences in bioimpedance distribution.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the normal bioimpedance characteristics of neonates, aiding in better health assessments.
How similar studies have gone: While this approach is observational and may have been used in other contexts, the specific application of bioimpedance vector analysis in healthy neonates is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Healthy term neonates of both sexes within 24 hours. 2. Neonates whose parents or guardians consent with the research. Exclusion Criteria: 1. Infants with some disease and conditions that could interfere in the body composition (such as heart failure, blue light irradiation, sepsis, kidney injury, hepatic failure, transfusion) and newborns with congenital anomalies and/or genetic problems. 2. Neonates whose parents or guardians refuse to participate in the research.
Where it's running
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Tian Zhichen, master
- Email: tianzhichen63@163.com
- Phone: +8613066385364
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Metabolic Health Trajectories in Overweight Chinese Adults
This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.
-
Theta-burst temporal interference stimulation to improve awareness in people with disorders of consciousness
This study will test whether theta-burst patterned temporal interference stimulation (tTIs) can help adults with recent disorders of consciousness (vegetative or minimally conscious) show more signs of awareness.
-
Probiotic LR607 with neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer
The team will try giving adults with resectable stage IB–IIIC non-small cell lung cancer a daily probiotic (Lactobacillus rhamnosus LR607) alongside neoadjuvant chemoimmunotherapy to see if it improves tumor response and is safe.
-
Low- versus high-dose nafamostat for anticoagulation during CRRT in ICU patients
This study tests whether starting nafamostat at 50 mg/h rather than 20 mg/h keeps CRRT filters from clotting longer in adult ICU patients on continuous renal replacement therapy.
-
Anrikefen vs Nalfurafine for sleep quality in kidney disease patients with itching
A randomized, open-label study tests whether the injectable Anrikefen improves sleep better than the oral nalfurafine in adults on hemodialysis with CKD-associated itching.
-
Luspatercept to treat anemia after donor stem cell transplant
This trial will try luspatercept in people with acute leukemia who have anemia after an allogeneic (donor) stem cell transplant to see if it raises hemoglobin without transfusions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.